Search

everythinglearnresearchcommunity

for

Search:↓

Ajwain seed extract improved skin healing and hair growth in a mouse skin irritation model.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

High levels of HSP70 and IL-15 are linked to more severe alopecia areata.

IL10_ApoEVs improve skin healing and reduce scarring.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

A 3-month treatment improved PCOS symptoms and reduced certain immune proteins.

Alopecia areata patients have higher IgE and IL-13 levels, suggesting immune involvement.

Higher IL-17A levels indicate more severe alopecia areata.

People with severe hair loss have higher levels of a protein called interleukin 17 in their blood.

Patients with Alopecia Areata have higher levels of certain inflammatory markers.

Treatment improved PCOS symptoms and reduced BMI and certain immune factors.

Targeting Interleukin-13 could help treat alopecia areata linked with atopic dermatitis.

Higher Interleukin 17A levels may indicate more severe alopecia areata.

Targeting IL-15 may help treat Alopecia Areata.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Higher IL-19 levels are linked to more severe Alopecia Areata.

Atopy and altered T cell functions contribute to Alopecia Areata.

PRP treatment reduces inflammation and increases interleukin-10 in alopecia areata patients.

Certain gene variations are linked to alopecia areata.

Interleukin 6 may help protect skin without causing inflammation.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

A man's gray hair got darker and thicker after using a psoriasis drug.

The study was retracted.

Higher IL-37 levels are linked to more severe alopecia areata, but the gene variation doesn't affect disease risk.

A mutation in the IL2RA gene increases the risk of alopecia areata.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Targeting IL-17 could help treat pattern hair loss.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.